A.R. Knight

2.3k total citations · 1 hit paper
16 papers, 1.8k citations indexed

About

A.R. Knight is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, A.R. Knight has authored 16 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 2 papers in Organic Chemistry. Recurrent topics in A.R. Knight's work include Neuroscience and Neuropharmacology Research (6 papers), Receptor Mechanisms and Signaling (4 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). A.R. Knight is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Receptor Mechanisms and Signaling (4 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). A.R. Knight collaborates with scholars based in United States and United Kingdom. A.R. Knight's co-authors include Erik H.F. Wong, J A Kemp, Tony Priestley, G.N. Woodruff, L L Iversen, Norman G. Bowery, Derek N. Middlemiss, Aditya Misra, R. J. Gillespie and Colin T. Dourish and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Journal of Medicinal Chemistry.

In The Last Decade

A.R. Knight

16 papers receiving 1.7k citations

Hit Papers

The anticonvulsant MK-801 is a potent N-methyl-D-aspartat... 1986 2026 1999 2012 1986 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.R. Knight United States 7 1.4k 1.0k 231 174 149 16 1.8k
D Lodge United Kingdom 14 1.1k 0.8× 811 0.8× 175 0.8× 240 1.4× 127 0.9× 26 1.5k
Elizabeth J. Fletcher Canada 17 1.7k 1.2× 1.3k 1.3× 270 1.2× 181 1.0× 101 0.7× 23 2.0k
Nigel R. Newberry United Kingdom 22 1.6k 1.1× 1.1k 1.1× 450 1.9× 182 1.0× 169 1.1× 51 1.9k
D D Schoepp United States 15 1.5k 1.0× 922 0.9× 419 1.8× 136 0.8× 76 0.5× 18 1.8k
Cristina Cosi France 27 1.1k 0.8× 939 0.9× 150 0.6× 223 1.3× 200 1.3× 51 2.1k
Ashok K. Mehta United States 22 1.5k 1.1× 854 0.8× 362 1.6× 187 1.1× 91 0.6× 45 2.2k
John W. Ferkany United States 28 1.8k 1.2× 1.3k 1.3× 306 1.3× 351 2.0× 188 1.3× 59 2.5k
Christian Thomsen Denmark 21 1.3k 0.9× 1.0k 1.0× 168 0.7× 243 1.4× 125 0.8× 38 1.9k
M. Teresa Vilaró Spain 28 1.8k 1.3× 1.5k 1.4× 314 1.4× 166 1.0× 94 0.6× 44 2.4k
J.C. Blanchard France 23 1.4k 1.0× 977 1.0× 264 1.1× 418 2.4× 129 0.9× 56 2.1k

Countries citing papers authored by A.R. Knight

Since Specialization
Citations

This map shows the geographic impact of A.R. Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.R. Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.R. Knight more than expected).

Fields of papers citing papers by A.R. Knight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.R. Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.R. Knight. The network helps show where A.R. Knight may publish in the future.

Co-authorship network of co-authors of A.R. Knight

This figure shows the co-authorship network connecting the top 25 collaborators of A.R. Knight. A scholar is included among the top collaborators of A.R. Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.R. Knight. A.R. Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
3.
Dourish, Colin T., Adams, Karen Benwell, et al.. (2004). Discovery and development of selective 5-HT2C receptor agonists for obesity. Fundamental and Clinical Pharmacology. 18. 127–127. 2 indexed citations
4.
Weiss, Scott Μ., Karen Benwell, Ian A. Cliffe, et al.. (2003). Discovery of nonxanthine adenosine A2Areceptor antagonists for the treatment of Parkinson’s disease. Neurology. 61(11_suppl_6). S101–6. 64 indexed citations
5.
Knight, A.R., C Hartnett, Cara Marks, et al.. (1998). Molecular size of recombinant alpha1beta1 and alpha1beta1gamma2 GABAA receptors expressed in Sf9 cells.. PubMed. 6(1). 1–18. 5 indexed citations
6.
Knight, A.R. & Norman G. Bowery. (1996). The pharmacology of adenylyl cyclase modulation by GABAB receptors in rat brain slices. Neuropharmacology. 35(6). 703–712. 70 indexed citations
7.
Knight, A.R. & Norman G. Bowery. (1992). GABA receptors in rats with spontaneous generalized nonconvulsive epilepsy. PubMed. 35. 189–196. 36 indexed citations
8.
Russell, Michael G. N., R. BAKER, David C. Billington, et al.. (1992). Benz[f]isoquinoline analogs as high-affinity .sigma. ligands. Journal of Medicinal Chemistry. 35(11). 2025–2033. 22 indexed citations
9.
Knight, A.R., Christina Wyatt, & Derek N. Middlemiss. (1991). Spironolactone causes a rapid down regulation of sigma recognition sites in guinea pig brain and liver. Neuropharmacology. 30(8). 923–925. 5 indexed citations
10.
Knight, A.R., John W. Gillard, Erik H.F. Wong, & Derek N. Middlemiss. (1991). The human σ site, which resembles that in NCB20 cells, may correspond to a low-affinity site in guinea pig brain. Neuroscience Letters. 131(2). 233–236. 6 indexed citations
11.
Lyle, Terry A., Catherine Magill, Susan F. Britcher, et al.. (1990). Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801). Journal of Medicinal Chemistry. 33(3). 1047–1052. 10 indexed citations
12.
Tricklebank, Mark D., T. Honoré, S.D. Iversen, et al.. (1990). The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor. British Journal of Pharmacology. 101(3). 753–761. 31 indexed citations
13.
Wong, Erik H.F., J A Kemp, Tony Priestley, et al.. (1986). The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.. Proceedings of the National Academy of Sciences. 83(18). 7104–7108. 1533 indexed citations breakdown →
14.
Barnes, Joanne, Peter Drew, Jeffrey M P Holly, et al.. (1985). Effect of angiotensin converting-enzyme inhibition on potassium-mediated aldosterone secretion in essential hypertension. Clinical Science. 68(6). 625–630. 3 indexed citations
15.
Drew, Peter, Joanne Barnes, Jeffrey M P Holly, A.R. Knight, & F. J. Goodwin. (1984). The Effects of a Chronic Infusion of Arginine Vasopressin in Salt-Restricted, Water-Deprived Man. Clinical Science. 67(3). 353–358. 6 indexed citations
16.
Karakiulakis, George, et al.. (1978). Sexual dimorphism in the number of dopamine receptors in limbic and non-limbic areas of rat brain [proceedings].. PubMed. 79(2). 32P–33P. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026